Geleijns K - Search Results

1

Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.

Geleijns K, Roos A, Houwing-Duistermaat JJ, van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA, Jacobs BC. Geleijns K, et al. J Immunol. 2006 Sep 15;177(6):4211-7. doi: 10.4049/jimmunol.177.6.4211. J Immunol. 2006. PMID: 16951387

2

Severity of Guillain-Barré syndrome is associated with Fc gamma Receptor III polymorphisms.

van Sorge NM, van der Pol WL, Jansen MD, Geleijns KP, Kalmijn S, Hughes RA, Rees JH, Pritchard J, Vedeler CA, Myhr KM, Shaw C, van Schaik IN, Wokke JH, van Doorn PA, Jacobs BC, van de Winkel JG, van den Berg LH. van Sorge NM, et al. J Neuroimmunol. 2005 May;162(1-2):157-64. doi: 10.1016/j.jneuroim.2005.01.016. J Neuroimmunol. 2005. PMID: 15833371

3

The occurrence of Guillain-Barre syndrome within families.

Geleijns K, Brouwer BA, Jacobs BC, Houwing-Duistermaat JJ, van Duijn CM, van Doorn PA. Geleijns K, et al. Neurology. 2004 Nov 9;63(9):1747-50. doi: 10.1212/01.wnl.0000143055.09646.31. Neurology. 2004. PMID: 15534275

4

HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.

Geleijns K, Schreuder GM, Jacobs BC, Sintnicolaas K, van Koningsveld R, Meulstee J, Laman JD, van Doorn PA. Geleijns K, et al. Neurology. 2005 Jan 11;64(1):44-9. doi: 10.1212/01.WNL.0000148727.02732.01. Neurology. 2005. PMID: 15642902

5

Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.

Geleijns K, Jacobs BC, Van Rijs W, Tio-Gillen AP, Laman JD, van Doorn PA. Geleijns K, et al. J Neuroimmunol. 2004 May;150(1-2):132-8. doi: 10.1016/j.jneuroim.2004.01.003. J Neuroimmunol. 2004. PMID: 15081257

6

Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.

Geleijns K, Laman JD, van Rijs W, Tio-Gillen AP, Hintzen RQ, van Doorn PA, Jacobs BC. Geleijns K, et al. J Neuroimmunol. 2005 Apr;161(1-2):183-9. doi: 10.1016/j.jneuroim.2004.12.001. J Neuroimmunol. 2005. PMID: 15748958

7

Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA.

Kuijf ML, van Doorn PA, Tio-Gillen AP, Geleijns K, Ang CW, Hooijkaas H, Hop WC, Jacobs BC. Kuijf ML, et al. Among authors: geleijns k. J Neurol Sci. 2005 Dec 15;239(1):37-44. doi: 10.1016/j.jns.2005.07.009. Epub 2005 Sep 8. J Neurol Sci. 2005. PMID: 16154154

8

Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.

Geleijns K, Emonts M, Laman JD, van Rijs W, van Doorn PA, Hermans PW, Jacobs BC. Geleijns K, et al. J Neuroimmunol. 2007 Oct;190(1-2):127-30. doi: 10.1016/j.jneuroim.2007.07.008. Epub 2007 Aug 30. J Neuroimmunol. 2007. PMID: 17761309

9

Subclass IgG to motor gangliosides related to infection and clinical course in Guillain-Barré syndrome.

Jacobs BC, Koga M, van Rijs W, Geleijns K, van Doorn PA, Willison HJ, Yuki N. Jacobs BC, et al. Among authors: geleijns k. J Neuroimmunol. 2008 Feb;194(1-2):181-90. doi: 10.1016/j.jneuroim.2007.11.017. Epub 2008 Feb 21. J Neuroimmunol. 2008. PMID: 18178257

10

Susceptibility to Guillain-Barré syndrome is not associated with CD1A and CD1E gene polymorphisms.

Kuijf ML, Geleijns K, Ennaji N, van Rijs W, van Doorn PA, Jacobs BC. Kuijf ML, et al. Among authors: geleijns k. J Neuroimmunol. 2008 Dec 15;205(1-2):110-2. doi: 10.1016/j.jneuroim.2008.08.013. Epub 2008 Oct 5. J Neuroimmunol. 2008. PMID: 18838176

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters